期刊文献+

幽门螺杆菌Lpp20重组蛋白的表达、纯化及其免疫活性初步研究 被引量:1

Expression and purification of the Lpp20 recombinant protein of Helicobacter pylori and primary study on its immunocompetence
下载PDF
导出
摘要 目的表达幽门螺杆菌(Helicobacter pylori,H.pylori)脂蛋白Lpp20基因的重组蛋白,并检测其免疫活性。方法应用PCR技术从H.pylori标准株26695染色体DNA中扩增出Lpp20的编码基因片段,将其克隆至表达载体pGEX-6P-2上,在大肠杆菌(Escherichia coli,E.coli)BL21中表达并进行GST亲和层析纯化,用Western blot方法检测纯化产物重组Lpp20(recombinantLpp20,rLpp20)的免疫反应性。免疫C57BL/6小鼠后,以rLpp20为包被抗原建立间接ELISA法对免疫小鼠血清进行特异性抗体检测;ELISA双抗体夹心法检测小鼠脾淋巴细胞培养上清中IFN-γ、IL-2、IL-4水平;MTT比色法检测小鼠脾淋巴细胞增殖反应等指标以分析rLpp20的免疫活性。结果扩增的lpp20全长528 bp,与GenBank上公布的H.pylori 26695株lpp20序列作BLAST比较,结果完全一致;成功构建了pGEX-6P-2/Lpp20重组质粒,表达的rLpp20 M_r 43 000,纯化产物可被鼠抗H.pylori抗体识别;以rLpp20为包被抗原建立的间接ELISA法检测免疫小鼠血清,与对照组相比rLpp20免疫组可见阳性反应;rLpp20免疫组小鼠脾淋巴细胞经特异性抗原刺激后,培养上清中IFN-γ、IL-2和IL-4含量均明显升高;脾淋巴细胞增殖反应测定,rLpp20免疫组小鼠脾淋巴细胞经特异性抗原刺激后,刺激指数也明显升高,与对照组有明显差异。结论rLpp20具有良好的免疫活性,在小鼠体内可诱导较强的特异性体液免疫和细胞免疫应答,为筛选高效的H.pylori疫苗抗原奠定了基础。 We aimed to express recombinant Lpp20 protein of Helicobacter pylori and study its immunocompetence.We amplified Lpp20 gene by polymerase chain reaction(PCR) and obtained Lpp20 gene fragments(528 bp).Then subcloned the fragment into the expression vector pGEX-6P-2 to generate recombinant plasmid pGEX-6P-2/Lpp20.Recombinant Lpp20(rLpp20) was expressed in Escherichia coli(E.coli) BL21 and purified by GST affinity chromatograph,thus we obtained a soluble fusion protein with molecular weight about 43 000.Then we analyzed the immunoreactivity of rLpp20 by Western blotting and found that rLpp20 could be recognized by the polyclonal mouse anti-H.pylori antibody.Six weeks old C57BL/6 mice were immunized with purified rLpp20,GST,or Elution buffer intramuscularly at 2-week interval for four times.ELISA showed significant specific antibody titers,and demonstrated that the cytokines IFN-γ,IL-2,and IL-4 in mice spleen lymphocyte culture medium after stimulating by rLpp20 were increased significantly in rLpp20 groups.By using MTT assay,we found that the proliferation response of spleen cells of rLpp20 group was significantly higher than those of mice in control group.All these results suggest that rLpp20 protein has good immunocompetence and can induce strong humoral and cellular immunity in C57BL/6 mice,which lay a foundation for further development of effective vaccine against H.pylori infection.
出处 《免疫学杂志》 CAS CSCD 北大核心 2010年第5期423-427,437,共6页 Immunological Journal
基金 湖南省自然科学基金优秀面上项目(06JJ2093) 湖南省教育厅优秀青年项目(08B067)
关键词 幽门螺杆菌 LPP20 重组蛋白 蛋白表达 免疫活性 Helicobacter pylori Lpp20 Recombinant protein Protein expression Immunocompetence
  • 相关文献

参考文献15

  • 1Weck MN, Brenner H. Association of Helieobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition[J]. Int J Cancer, 2008, 123 (4):874-881.
  • 2Robinson K, Kenefeck R, Pidgeon EL, et al. Helicobacter pylori-induced peptic ulcer disease is associated with inadequate regulatory T cell responses [J]. Gut, 2008,57(10): 1375-1385.
  • 3Santacroce L, Cagiano R, Del Prete R, et al. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight[J]. Clin Ter, 2008, 159(6):457-462.
  • 4Hatakeyama M. Helicobacter pylori and gastric carcinogenesis [J]. J Gastroenterol, 2009, 44 (4): 239-248.
  • 5Vorobjova T, Watanabe T, Chiba T. Helicobacter pylori immunology and vaccines[J]. Helicobacter, 2008,13 (Suppl 1): 18-22.
  • 6Keenan J, Oliaro J, Domigan N, et al. Immune response to an 18-kilodahon outer membrane antigen identifies lipoprotein 20 as a Helicobaeter pylori vaccine candidate [J]. Infect Immun, 2000, 68 (6): 3337-3343.
  • 7颜子颖 王海林 译.精编分子生物学实验指南[M].北京:科学出版社,1998..
  • 8Kostrzynska M, O'Toole PW, Taylor DE, et al. Molecular characterization of a conserved 20-kilodalton membrane- associated lipoprotein antigen of Helicobacter pylori [J]. J Bacteriol, 1994, 176 (19): 5938-5948.
  • 9Cao P, McClain MS, Forsyth MH, et al. Extracellular release of antigenic proterins by Helicobacter pylori [J]. Infect Immun, 1998, 66 (6): 2984-2986.
  • 10刘志杰,张艳,黎村艳,邱宏,余敏君.幽门螺杆菌Lpp20核酸疫苗的构建及其免疫活性的初步研究[J].中华微生物学和免疫学杂志,2008,28(11):1035-1039. 被引量:3

二级参考文献38

  • 1郭红,邹全明,赵哓晏.幽门螺杆菌疫苗免疫机制的研究进展[J].免疫学杂志,2001,17(z1):49-52. 被引量:1
  • 2周维英,吴超,石云,张卫军,邹全明.幽门螺杆菌双亚单位表位融合蛋白的构建、表达及鉴定[J].免疫学杂志,2007,23(2):121-125. 被引量:4
  • 3邓颖,杨致邦,王勇,黄进,张绍兰,叶翠莲.幽门螺杆菌napA-ctxB融合蛋白的基因克隆与表达[J].免疫学杂志,2007,23(2):172-175. 被引量:2
  • 4Seoane A, Bessa X, Balleste B, et al. Helicobacter pylori and gastric cancer: relationship with histological subtype and tumor location. Gastroenterol Hepatol, 2005, 28(2): 60-64.
  • 5Blanchard TG, Drakes ML, Czinn SJ. Helicobacter infection: pathogenesis. Curt Opin Gastroenterol, 2004, 20( 1 ) : 10-15.
  • 6Wallis-Crespo MC, Crespo A. Helicobacter pylori infection in pediatric population: epidemiology, pathophysiology, and therapy. Fetal Pediat Pathol, 2004, 23 ( 1 ) : 11-28.
  • 7Kostrzynska M, O'Toole PW, Taylor DE, et al. Molecular characterization of a conserved 20-kilodahon membrane-associated lipoprotein antigen of Helicobacter pylori.J Bacteriol, 1994, 176 (19) : 5938-5948.
  • 8Keenan J, Oliaro J, Domigan N, et al. Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate. Infect Immune, 2000, 68 (6) : 3337-3343.
  • 9Keenan JI, Rijpkema SG, Durrani Z, et al. Differences in immunogenicity and protection in mice and guinea pigs following intranasal immunization with Helicobacter pylori outer membrane antigens. FEMS Immunol Med Mierobiol, 2003, 36(3) : 199-205.
  • 10Cao P, McClain MS, Forsyth MH, et al. Extracellular release of antigenic proterins by Helicobacter pylori. Infect Immune, 1998, 66(6) : 2984-2986.

共引文献81

同被引文献9

  • 1Santacroce L,Cagiano R,Del Prete R,et a1.Helicobacter pylori infection and gastric MALTomas:an up-to-date and therapy highlight[J].Clin Ter,2008,159(6) :457-462.
  • 2Kao CY,Sheu BS,Sheu SM,et al.Higher motility enhances bacterial density and inflammatory response in dyspeptic patients infected with Helicobacter pylori[J].Helicobacter,2012, 17(6) :411-416.
  • 3Elzouki AN,Buhjab SI,Alkialani A,et al.Gastric cancer and Helicobacter pylori infect-ion in the Eastern Libya:A descriptive epidemiological study [J].Arab J Gastroenterol,2012,13(2):85-88.
  • 4World Gastroenterology. Organisation.World gastroenterology organisation global gu-ideline: Helicobacter pylori in developing cotintries [ J ] .J Clin Gastroenterol, 2011,45 ( 5 ) : 383-388.
  • 5Warren JR,Marshall BJ.Unidentified curved bacilli on gastric' epithelium in active chronic gastritis[J]. Lancet, 1983,1 (8336) : 1273-1275.
  • 6Taylor JM,Ziman ME,Fong J,et al.Possible correlates of long- term protection against Helicobacter pylori following systemic orcombinations of mucosal and systemic immunizations [J].Infect Immun, 2007,75 (7) : 3462-3469.
  • 7胡宏波,梁秀兰,何建明.PTPN11第3内含子基因多态性及H.pylori感染与广西柳州地区胃癌易感性研究[J].热带医学杂志,2009,9(11):1233-1237. 被引量:4
  • 8于文,张艳,靖吉芳,刘志杰.幽门螺杆菌Lpp20-IL2核酸疫苗免疫活性[J].微生物学报,2010,50(4):554-559. 被引量:6
  • 9张荣光,段广才,范清堂.利用生物信息学分析幽门螺杆菌Lpp20蛋的化学和免疫学分子特征[J].河南预防医学杂志,2003,14(4):193-195. 被引量:3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部